awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39044162-065E7A51-48C9-4354-93CF-B4A612DDC354
Q39044162-065E7A51-48C9-4354-93CF-B4A612DDC354
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39044162-065E7A51-48C9-4354-93CF-B4A612DDC354
Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?
P2860
Q39044162-065E7A51-48C9-4354-93CF-B4A612DDC354
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39044162-065E7A51-48C9-4354-93CF-B4A612DDC354
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
171331721492d2a616bf389c29dc340900bf71aa
P2860
A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).